Chen et al. demonstrated that kefir peptides can exert anti-inflammatory and antifibrotic effects on target organs of spontaneous hypertension by simultaneously reducing the expression of ET-1 and NLRP3 [37]. This evidence concerns the gene NLRP3 and hypertensive disorder.